PortfoliosLab logo

Emergent BioSolutions Inc. (EBS)

Equity · Currency in USD
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
ISIN
US29089Q1058
CUSIP
29089Q105

EBSPrice Chart


Chart placeholderClick Calculate to get results

EBSPerformance

The chart shows the growth of $10,000 invested in Emergent BioSolutions Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $42,540 for a total return of roughly 325.40%. All prices are adjusted for splits and dividends.


EBS (Emergent BioSolutions Inc.)
Benchmark (S&P 500)

EBSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD20.13%-2.17%
1M27.86%0.62%
6M-13.59%6.95%
1Y-51.49%22.39%
5Y11.24%15.44%
10Y12.92%13.73%

EBSMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

EBSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Emergent BioSolutions Inc. Sharpe ratio is -0.83. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


EBS (Emergent BioSolutions Inc.)
Benchmark (S&P 500)

EBSDividends

Emergent BioSolutions Inc. granted a 0.00% dividend yield in the last twelve months, as of Jan 15, 2022. The annual payout for that period amounted to $0.00 per share.


PeriodTTM202120202019201820172016201520142013201220112010
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$1.86$0.00$0.00$0.00$0.00$0.00$0.00

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%5.65%0.00%0.00%0.00%0.00%0.00%0.00%

EBSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


EBS (Emergent BioSolutions Inc.)
Benchmark (S&P 500)

EBSWorst Drawdowns

The table below shows the maximum drawdowns of the Emergent BioSolutions Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Emergent BioSolutions Inc. is 75.46%, recorded on Nov 5, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-75.46%Aug 14, 2020311Nov 5, 2021
-48.32%Jun 1, 2011354Oct 23, 2012305Jan 13, 2014659
-45.49%Dec 4, 2018122May 31, 2019227Apr 24, 2020349
-38.4%Jun 7, 201615Jun 27, 2016316Sep 27, 2017331
-29.08%Mar 11, 2014152Oct 14, 201463Jan 14, 2015215
-23.92%May 19, 202017Jun 11, 202018Jul 8, 202035
-21.45%Dec 31, 201553Mar 17, 201625Apr 22, 201678
-20.71%Aug 12, 201536Oct 1, 201527Nov 9, 201563
-16.86%Apr 4, 201136May 24, 20114May 31, 201140
-15.93%Jan 11, 201135Mar 2, 201122Apr 1, 201157

EBSVolatility Chart

Current Emergent BioSolutions Inc. volatility is 51.47%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


EBS (Emergent BioSolutions Inc.)
Benchmark (S&P 500)

Portfolios with Emergent BioSolutions Inc.


Loading data...

More Tools for Emergent BioSolutions Inc.